3
Participants
Start Date
April 30, 2024
Primary Completion Date
May 17, 2024
Study Completion Date
May 17, 2024
ellacor® Micro-Coring procedure
ellacor® Micro-Coring Technology is FDA approved for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.
Dallas Plastic Surgery Institute, Dallas
Lead Sponsor
Dallas Plastic Surgery Institute
OTHER
Cytrellis Biosystems, Inc.
INDUSTRY